Archive: 08/12/2015

Kanuma approved for rare missing-enzyme disease

(HealthDay)—Kanuma (sebelipase alfa) has been approved by the U.S. Food and Drug Administration as the first treatment for a rare but often-deadly disease caused by an enzyme deficiency.

page 2 from 10